| David Kerr, DO | |
|
1323 W 6th Ave, Stillwater, OK 74074-4306 | |
| (405) 372-1480 | |
| Not Available |
| Full Name | David Kerr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 1323 W 6th Ave, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629048186 | NPI | - | NPPES |
| 50036568 | Other | RAILROAD MEDICARE | |
| 440702050001 | Other | OK | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2876 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stillwater Medical Center Authority | 2365353794 | 143 |
News Archive
The results of three clinical trials published on Wednesday in the New England Journal of Medicine show that the antiretroviral drug Truvada, a combination of tenofovir and emtracitabine, can be "highly effective at preventing infection in HIV-free individuals - as long as those individuals take the drug every day as prescribed," CNN's "The Chart" reports (7/11).
Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.
New combinations of agents based on the oldest synthetic malaria drug, the methylene blue stain, can curb the spread of malaria parasites and make a significant contribution to the long-term eradication called for by the international "Roll Back Malaria Initiative."
Researchers Mario Guarracino from the HSE Laboratory of Algorithms and Technologies for Networks Analysis in Nizhny Novgorod and Julius Žilinskas and Algirdas Lančinskas from Vilnius University, have proposed a new method of testing for COVID-19.
› Verified 2 days ago
| Entity Name | Stillwater Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
The results of three clinical trials published on Wednesday in the New England Journal of Medicine show that the antiretroviral drug Truvada, a combination of tenofovir and emtracitabine, can be "highly effective at preventing infection in HIV-free individuals - as long as those individuals take the drug every day as prescribed," CNN's "The Chart" reports (7/11).
Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.
New combinations of agents based on the oldest synthetic malaria drug, the methylene blue stain, can curb the spread of malaria parasites and make a significant contribution to the long-term eradication called for by the international "Roll Back Malaria Initiative."
Researchers Mario Guarracino from the HSE Laboratory of Algorithms and Technologies for Networks Analysis in Nizhny Novgorod and Julius Žilinskas and Algirdas Lančinskas from Vilnius University, have proposed a new method of testing for COVID-19.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Kerr, DO Po Box 1029, Stillwater, OK 74076-1029 Ph: (405) 742-5300 | David Kerr, DO 1323 W 6th Ave, Stillwater, OK 74074-4306 Ph: (405) 372-1480 |
News Archive
The results of three clinical trials published on Wednesday in the New England Journal of Medicine show that the antiretroviral drug Truvada, a combination of tenofovir and emtracitabine, can be "highly effective at preventing infection in HIV-free individuals - as long as those individuals take the drug every day as prescribed," CNN's "The Chart" reports (7/11).
Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.
New combinations of agents based on the oldest synthetic malaria drug, the methylene blue stain, can curb the spread of malaria parasites and make a significant contribution to the long-term eradication called for by the international "Roll Back Malaria Initiative."
Researchers Mario Guarracino from the HSE Laboratory of Algorithms and Technologies for Networks Analysis in Nizhny Novgorod and Julius Žilinskas and Algirdas Lančinskas from Vilnius University, have proposed a new method of testing for COVID-19.
› Verified 2 days ago
Inge Hayes, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-372-1480 | |
Jack Shearer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-372-1480 | |
Elizabeth Biernat, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-372-1480 |